The Chemours Company has provided an update on its second quarter 2025 outlook, revealing stronger-than-expected performance in several segments. The Thermal & Specialized Solutions $(TSS)$ segment anticipates a 25% sequential increase in Net Sales, driven by robust demand for Opteon™ Refrigerants, linked to the transition to low global warming potential refrigerants under the U.S. AIM Act. This demand is expected to result in a nearly 40% sequential rise in Adjusted EBITDA for TSS. The company's overall consolidated Net Sales for the quarter are projected to be at the high end of the original range, with a sequential mid-teens increase. Consolidated Adjusted EBITDA is forecasted to be between $215 and $225 million, and consolidated Free Cash Flow is expected to remain positive. In the Titanium Technologies $(TT)$ segment, Net Sales are anticipated to align with high single-digit growth expectations. However, Adjusted EBITDA for TT is expected to decline by approximately 15% sequentially, due to operational disruptions from a rail line service interruption that led to a $15 million increase in costs from using higher-cost ore feedstock, along with $10 million in costs from other operational issues. The Advanced Performance Materials $(APM.AU)$ segment is projected to see a nearly 25% sequential increase in Adjusted EBITDA, attributed to stronger cost performance, while Net Sales are expected to meet original low teens sequential growth expectations. The company also noted slightly higher-than-expected overall corporate costs due to ongoing litigation in New Jersey. A comprehensive update will be provided in connection with the second quarter earnings process.